Diet and Exercise for Post-COVID Syndrome
(MARVEL Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how a weight loss program, combining diet and exercise, can help manage symptoms in obese Veterans with Post-COVID Conditions (PCC). The goal is to determine if losing weight can reduce inflammation and improve physical functioning and quality of life. Participants will either follow a 12-week weight loss plan with diet and exercise or a weight stability plan with education and stretching. Veterans who had COVID-19 more than 90 days ago, have experienced ongoing symptoms for at least four weeks, and are either lean (BMI 19-25) or obese (BMI 30-50) might be a good fit for this study. As an unphased trial, this study offers Veterans a unique opportunity to contribute to understanding how lifestyle changes can improve health outcomes post-COVID.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it excludes those using anti-coagulant medications. It's best to discuss your specific medications with the trial coordinators.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that weight loss programs combining diet and exercise are generally safe and can aid individuals with long COVID. For instance, one study found that a remote weight management plan improved health for those with long COVID and extra weight. Another study demonstrated that dietary changes, such as personalized nutrition advice, enhanced physical performance in these patients.
Exercise plays a crucial role as well. A review of several studies found that both resistance exercises (like weight lifting) and aerobic exercises (like walking or cycling) improved the quality of life for people recovering from COVID-19. These findings suggest that diet and exercise plans are well-tolerated and can safely support recovery from Post-COVID Conditions.12345Why are researchers excited about this trial?
Researchers are excited about the Diet and Exercise for Post-COVID Syndrome trial because it offers a new approach to managing post-COVID symptoms through lifestyle modifications. Unlike traditional treatments that often focus on medications to manage individual symptoms, this trial emphasizes a holistic approach with structured weight loss and stability programs. The weight loss arm combines nutrition and exercise, which could improve overall health and potentially reduce post-COVID symptoms by enhancing physical fitness and resilience. Meanwhile, the weight stability arm focuses on maintaining balance and flexibility, which might help alleviate fatigue and improve quality of life for those with ongoing post-COVID issues. This integrated method could offer a sustainable and comprehensive way to manage post-COVID syndrome, making it an exciting area of exploration for researchers.
What evidence suggests that this trial's treatments could be effective for Post-COVID Syndrome?
This trial will compare a weight loss program with a weight stability program for individuals with post-COVID syndrome. Studies have shown that weight loss programs can help reduce symptoms of Long COVID. Specifically, one trial found that a remote weight management plan led to fewer Long COVID symptoms in overweight individuals. Research also highlights the importance of combining exercise and diet to aid recovery from COVID-19. Together, exercise and good nutrition can improve both breathing and muscle issues during recovery. Overall, this approach is safe and beneficial for those dealing with post-COVID conditions.56789
Who Is on the Research Team?
Alice S. Ryan, PhD
Principal Investigator
Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Are You a Good Fit for This Trial?
This trial is for older U.S. Veterans who are either overweight or obese, with a BMI of 19-25 or 30-40 kg/m2. It's suitable for those with no Post-COVID symptoms or at least one symptom lasting more than four weeks. Women must be postmenopausal. Participants should not have conditions affecting study assessments, significant weight change recently, use anticoagulants, uncontrolled diabetes, active diseases including inflammatory and autoimmune, nor substance abuse issues.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants will undergo a weight loss intervention including dietary modification and exercise, or a weight stability program with health education and stretching/balance classes
Follow-up
Participants are monitored for changes in cardiorespiratory fitness and adipose tissue cellular senescence
What Are the Treatments Tested in This Trial?
Interventions
- 12-weeks of Weight Loss
- 12-weeks of Weight Stability
Find a Clinic Near You
Who Is Running the Clinical Trial?
VA Office of Research and Development
Lead Sponsor
Baltimore VA Medical Center
Collaborator
South Texas Veterans Health Care System
Collaborator
Baltimore Veterans Affairs Medical Center
Collaborator